Observational study on the efficacy of adalimumab for the treatment of ulcerative colitis and predictors of outcome

Faubion, 2001, The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study, Gastroenterology, 121, 255, 10.1053/gast.2001.26279 Cohen, 2010, Systematic review: costs of ulcerative colitis in western countries, Aliment Pharmacol Ther, 31, 693, 10.1111/j.1365-2036.2010.04234.x Rutgeerts, 2005, Infliximab for induction and maintenance therapy for ulcerative colitis, N Engl J Med, 353, 2462, 10.1056/NEJMoa050516 Järnerot, 2005, Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study, Gastroenterology, 128, 1805, 10.1053/j.gastro.2005.03.003 Reinisch, 2011, Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial, Gut, 60, 780, 10.1136/gut.2010.221127 Sandborn, 2012, Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitis, Gastroenterology, 142, 257, 10.1053/j.gastro.2011.10.032 Afif, 2009, Open-label study of adalimumab in patients with ulcerative colitis including those with prior loss of response or intolerance to infliximab, Inflamm Bowel Dis, 15, 1302, 10.1002/ibd.20924 Peyrin-Biroulet, 2007, Long-term outcome of adalimumab therapy for ulcerative colitis with intolerance or lost response to infliximab: an open-label study, World J Gastroenterol, 13, 2328, 10.3748/wjg.v13.i16.2328 Taxonera, 2011, Adalimumab induction and maintenance therapy for patients with ulcerative colitis previously treated with infliximab, Aliment Pharmacol Ther, 33, 340, 10.1111/j.1365-2036.2010.04531.x Gies, 2010, Treatment of ulcerative colitis with adalimumab or infliximab: long-term follow-up of a single-centre cohort, Aliment Pharmacol Ther, 32, 522, 10.1111/j.1365-2036.2010.04380.x